In contrast, these authors observed no significant differences in survival among those patients with GNAQ mutations and those with GNA11 mutations in their study, even though they observed a trend toward increased survival among patients with tumours carrying a GNA11 mutations [19], which contradicted the evidence described so far. Here, GNA11 is linked to neoplasm.